Glycodesign's P2P Acquisition

Glycodesign raised a round of funding on April 09, 2003. Investors include Inflazyme Pharmaceuticals.

GLYCODesign is a publicly traded biopharmaceutical company engaged in the discovery and clinical development of glycotherapeutics for the treatment of cardiovascular diseases, inflammatory diseases, c…

Articles about Glycodesign's P2P Acquisition: